Last update:

Diabetes news

Diabetes

New insights into diabetes-related vision problems to inform treatment and prevention

A study published in Proceedings of the National Academy of Sciences details the role of the protein Pentraxin 3 (PTX3) in diabetic retinopathy, a leading cause of blindness and visual impairment.

Diabetes

A new injectable shows promise to prevent and treat hypoglycemia

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which can lead to dizziness, ...

Diabetes

Novel regulator of glucose transport in adipose tissue discovered

The role of the adapter protein PICALM (phosphatidylinositol-binding clathrin assembly protein) in the development of Alzheimer's disease is well documented. Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke ...

Diabetes

The hidden health risks of styrene and ethylbenzene exposure

Type 2 diabetes mellitus (T2DM) is a critical public health issue, with its prevalence expected to rise sharply worldwide. Recent evidence points to environmental pollution, specifically exposure to hazardous chemicals like ...

Diseases, Conditions, Syndromes

Study reveals how COVID-19 infection can cause or worsen diabetes

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens complications in people ...

Health

Better treatment for diabetic foot ulcers

People with type 2 diabetes often suffer from poorly-healing infected wounds on their feet. Using existing methods, however, it takes two days to grow a bacterial culture used to identify the pathogens infecting the wound ...

Medical research

Lipid produced by organism helps control blood sugar

Researchers based in Brazil, the United States and Germany have discovered that 12-HEPE, a lipid produced in response to cold by brown adipose tissue in the human body, helps reduce blood sugar. The results of their experiments ...

Diabetes

DPP4 inhibitors do not up risk of inflammatory bowel disease

(HealthDay)—Short-term use of a dipeptidyl peptidase 4 inhibitor (DPP4i) for the treatment of diabetes does not increase the risk of inflammatory bowel disease (IBD), according to a study published online Aug. 30 in Diabetes ...

Diabetes

Scientists identify potential way to prevent type 1 diabetes  

Researchers believe they have identified a way to prevent type 1 diabetes by restoring the immune system's natural balance. The approach may also prove effective for battling other autoimmune diseases such as lupus and eczema, ...

Diabetes

Designer type 2 diabetes drug comes with added benefits

A potential new treatment for type 2 diabetes has multiple, positive effects on health and metabolism in mice, reports a study in Nature. The new drug might have potential for treating a variety of disorders in addition to ...

Diabetes

Hormone therapy linked to decrease level of diabetes biomarkers

The Women's Health Initiative (WHI) remains one of the most highly quoted when debating the benefits and risks of hormone therapy. Now a new study based on WHI data demonstrates that, among other benefits, hormone therapy ...

Diabetes

Discontinuing insulin for older adults with type 2 diabetes

Patients with type 2 diabetes who were in poor health were more likely to continue taking insulin after age 75 than their counterparts in better health, according to Kaiser Permanente research published today in JAMA Internal ...

Medical research

New mechanism for dysfunctional insulin release identified

In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas. ...

Diabetes

Minorities more likely to have diabetes at lower weights

Being overweight or obese is commonly associated with diabetes, but a new Kaiser Permanente study finds the connection differs widely by race or ethnicity. Members of racial and ethnic minority groups were much more likely ...

Medications

Linagliptin noninferior for CV risk in early type 2 diabetes

(HealthDay)—Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal of the American Medical ...